Summary by Moomoo AI
KOJI PHARMACEUTICAL HOLDINGS LIMITED (HEREINAFTER REFERRED TO AS “KOZI PHARMACEUTICAL-B”) ISSUED A NOTICE TO NON-REGISTERED SHAREHOLDERS ON 30 APRIL 2024 ANNOUNCING THAT THE SUPPLEMENTAL CIRCULAR OF ITS ANNUAL GENERAL MEETING (THIS COMPANY'S PRESS RELEASE) HAS BEEN ISSUED. THE COMMUNICATION DOCUMENT IS AVAILABLE IN CHINESE AND ENGLISH AND CAN BE ACCESSED ON THE HKEX WEBSITE AND ON THE COMPANY'S WEBSITE. THE COMPANY HAS ISSUED CORPORATE COMMUNICATIONS ELECTRONICALLY PURSUANT TO SECTION 2.07A OF THE LISTING RULES EFFECTIVE DECEMBER 31, 2023 AND WILL BE CONSIDERED AT THE ANNUAL GENERAL MEETING IN MAY 2024 AFTER THE REVISED ARTICLES OF ASSOCIATION HAVE BEEN APPROVED BY SHAREHOLDERS. UNTIL THEN, THE COMPANY WILL CONTINUE TO SEND NOTICES OF PUBLICATION OF THE VERSION OF THE COMPANY'S NEWSLETTER TO SHAREHOLDERS BY EMAIL OR POST. Shareholders may make requests to the Company if they require printed communications. THE COMPANY ALSO REMINDS NON-REGISTERED SHAREHOLDERS TO UPDATE THEIR EMAIL ADDRESS TO ENSURE TIMELY RECEIPT OF COMPANY COMMUNICATIONS.